Abstract:Objective To prepare sinomenine hydrochloride(SIN-HCl) liposomes with high entrapment efficiency(EE) and to illustrate the effects of drug quantity and particle size on EE.Methods Centrifugation sedimentation-centrifugation ultrafiltration was employed to determine EE of liposomes.Thin film hydration(TFH),reverse phase evaporation(REV),and ether injection(EI) were screened based on EE and formability of liposomes.The effects of water type,pH value,ion concentration of hydration liquid,pH gradient active drug loading,lecithin-cholesterol ratio,and drug-lipid ratio on EE of liposomes were investigated.The relationship between EE and the factors affecting the drug quantity and particle size was probed with a comprehensive design experiment.The stability of typical liposomes was evaluated at 4 ℃.Results The optimal preparation technology was TFH for SIN-HCl liposomes and citrate buffer solution(CBS) was the best hydration liquid.The liposome EE increased with the increase of pH values of CBS.When the pH value of CBS was fixed,the EE increased as a result of decrease in the ion concentration of CBS.pH gradient active drug loading led to increase of EE.The preferable hydration liquid for liposomes was CBS with pH value of 2.5.The optimal ratio of soybean lecithin to cholesterol was 6∶1.Increasing ratios of SIN-HCl to soybean lecithin from 1∶6 to 6∶6 led to a slight decrease in EE of liposomes without probe signification.A quantitative relationship was established between the EE and drug quantity and liposome size.The EE of SIN-HCl liposomes prepared by certain particle size and drug quantity could reach over 80%.The typical liposomes showed a good stability.Conclusion The technology of pH gradient active drug loading is able to prepare SIN-HCl liposomes with high EE.

Optimization of Preparation of Angiotensin Converting Enzyme (ACE) Inhibitory Peptide RLSFNP Liposomes

Studies on Preparation of ACE Inhibitory Peptides Through Hydrolyzing of Casein by Enzymatic Membrane Reactor

Response surface methodology for the optimization of lactoferrin nano-liposomes

Response Surface Methodology for the Optimization of Beta-Lactoglobulin Nano-Liposomes

Optimization of Fabrication Parameters to Prepare Tea Catechin-Loaded Liposomes Using Response Surface Methodology

Preparation and Purification of Angiotensin-Converting Enzyme Inhibitory Peptides from Hydrolysate of Shrimp (litopenaeus Vannamei) Shell Waste

Enzymatic Preparation of Angiotensin Ⅰ-Converting Enzyme Inhibitory Peptides from Shrimp Shell

Optimization on Preparation Condition of Glycyrrhetinic Acid Liposome by Response Surface Methodology

Optimizing Preparation Conditions for Angiotensin-I-converting Enzyme Inhibitory Peptides Derived from Enzymatic Hydrolysates of Ovalbumin

Optimization of Enzymatic Hydrolysis Technology of Casein by Proteinases from Lactobacillus Helveticus for ACE Inhibitory Peptide Production

Optimization on Preparation Condition of Propolis Flavonoids Liposome by Response Surface Methodology and Research of Its Immunoenhancement Activity

Preparation Technology of Sinomenine Hydrochloride Liposomes

Preparation and Evaluation of Lipid Nanoparticles for Loading Enzyme Subtilisin FS33

Optimization of Encapsulation Using Milk Polar Lipid Liposomes with S-Layer Protein and Transport Study of the ACE-Inhibitory Peptide RLSFNP

Optimization of lipase-catalyzed synthesis of ginsenoside Rb1 esters using response surface methodology.

Optimization of Egg White Protein Enzymolysis for the Preparation of ACE Inhibitory Peptides

Study on Optimization of Formulation and Preparation Process of Ginsenoside Rg3 Liposomes

Transepithelial Transport Route and Liposome Encapsulation of Milk-Derived ACE-Inhibitory Peptide Arg-Leu-Ser-Phe-Asn-Pro.

Optimization of preparation technology and formulation of pingyangmycin liposomes by central composite design and response surface method

Optimization of BSA Freeze-Dried Liposome Prescription by Response Surface Methodology

Optimization of Hydrolysis Conditions for Production of Angiotensin-I Converting Enzyme(ACE)Inhibitory Peptide from Whey Protein Using Proteinases of Lactobacillus helveticus